{"version":"1.0","provider_name":"Alfasigma BE","provider_url":"https:\/\/be.alfasigma.com\/fr\/","title":"Alfasigma BE - R&D - GLOBAL","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"hZjofXqo1J\"><a href=\"https:\/\/be.alfasigma.com\/fr\/rd-global\/\">R&#038;D &#8211; GLOBAL<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/be.alfasigma.com\/fr\/rd-global\/embed\/#?secret=hZjofXqo1J\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0R&#038;D &#8211; GLOBAL\u00a0\u00bb &#8212; Alfasigma BE\" data-secret=\"hZjofXqo1J\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/be.alfasigma.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/be.alfasigma.com\/wp-content\/uploads\/2020\/12\/research-alfasigma-cz.jpg","thumbnail_width":1920,"thumbnail_height":1277,"description":"R&amp;D &#8211; GLOBAL Recherche et d\u00e9veloppement anim\u00e9s par l\u2019innovation Tout en soutenant les actifs existants et en d\u00e9veloppant de nouvelles indications pour r\u00e9pondre aux besoins non satisfaits, notre d\u00e9partement de recherche et d\u00e9veloppement se concentre sur trois domaines th\u00e9rapeutiques principaux : la gastroent\u00e9rologie, les maladies vasculaires et les troubles des neurosciences. Notre nouveau plan strat\u00e9gique &hellip; Continued"}